Phase not reported / not applicableCompletedOBSERVATIONAL
Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction
ClinicalTrials.gov · NCT06914141 · Registry updated: 2026-01-30
- Condition / research focus
- Diabetes Mellitus, Type 2; HFpEF - Heart Failure With Preserved Ejection Fraction
- Sponsor
- Brigham and Women's Hospital
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2025-01-14. Completion: 2025-06-01 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Tirzepatide (drug)
- Semaglutide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Brigham and Women's HospitalBoston, Massachusetts, United States